Filter posts

Patients Are at Core of Personalized Medicine Era

This week the Patient and Health Advocacy Summit concluded its sixth consecutive year, bringing hundreds …

Washington Post: Gene Therapies Offer “Dramatic Promise”

Yesterday’s Washington Post has an in-depth article about gene therapy, a type of therapeutic intervention which …

Wall Street Journal Highlights Promising Gene Therapy Advances

Yesterday, bluebird bio reported some very uplifting news at the annual meeting of the American …

2014 BIO Investor Forum Fireside Chat with Nick Leschly and Chris Collins

Nick Leschly has served as bluebird bio’s president and chief executive officer since September 2010. …

Foundation Fighting Blindness Invests in Gene Therapy Research Projects

Recently, the Foundation Fighting Blindness announced an $8.25 million investment in six new gene therapy …